Feel30 , a telehealth platform specializing in testosterone replacement therapy and men's hormone optimization, has introduced a care model designed to improve access to clinically supervised ...

The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...

Hormone therapy can affect collagen, hydration, and breakouts during menopause. Dermatologists explain the real skin benefits ...

Adding a small dose of healthy nuts, leafy green vegetables and dark chocolate are a great option to produce nitric oxide in ...

Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses ...

Stress has a direct impact on reproductive health. Constantly high cortisol levels can interfere with ovulation, menstrual ...

With the black box warning a thing of the past, interest in these once-controversial medications is growing, say experts.

On December 15, 2025, the U.S. Food and Drug Administration approved the medication Addyi for the treatment of hypoactive sexual desire disorder, or HSDD, in postmenopausal women under the age of 65 — ...

Andropause, or male menopause, occurs when testosterone and other vital hormones decline with age. When andropause hits, men experience low libido, fatigue, and mood swings. Understanding male ...

US President Donald Trump wants to speed up the reclassification of marijuana, from Schedule I to Schedule III.

Idaho Attorney General Raúl Labrador is leading a coalition of state prosecutors in voicing sharp opposition to the Trump ...

Advantech (TWSE: 2395), a global leader in intelligent IoT systems and embedded platforms, today announces the launch of MIPI ...